Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-896-0 | CAS number: 7360-38-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Absorption of propane-1,2,3-triyl 2-ethylhexanoate may be the highest after oral exposure, but may be limited at all due to the low water solubility. After enzymatic hydrolysis, the hydrolysis products may be absorbed and well distributed within the body. Glycerol is incorporated in standard metabolic pathways. 2-Ethylhexanoic acid may be metabolised by omega and omega-1 oxidation or by glucuronidation and subsequent renal excretion.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
In accordance with Annex VIII, Column 1, Item 8.8 of Regulation (EC) No. 1907/2006 (REACH) and with Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance (ECHA, 2017), assessment of the toxicokinetic behaviour of propane-1,2,3-triyl 2-ethylhexanoate (CAS 7360-38-5) was conducted to the extent that can be derived from the relevant available information on physico-chemical and toxicological characteristics. There are no studies available evaluating the toxicokinetic properties of the substance. Only limited information is available for the hydrolysis product 2-ethylhexanoic acid.
Absorption
Absorption is a function of the potential of a substance to diffuse across biological membranes. The most useful parameters providing information on this potential are the molecular weight, the octanol/water partition coefficient (log Pow) value and the water solubility. The log Pow value provides information on the relative solubility of the substance in water and lipids (ECHA, 2017).
No measured data are available regarding absorption, hydrolysis (before and after absorption), and the resulting systemic availability (concentration in blood) of propane-1,2,3-triyl 2-ethylhexanoate or its hydrolysis products. Therefore, no conclusion based on analytical data is possible regarding the correlation of propane-1,2,3-triyl 2-ethylhexanoate dosed to amount absorbed (parent compound/hydrolysis products).
Oral
When assessing the potential of propane-1,2,3-triyl 2-ethylhexanoate to be absorbed in the gastrointestinal (GI) tract, it has to be considered that carboxylic acid esters will undergo enzymatic hydrolysis by ubiquitously expressed GI esterases (Long, 1958; Lehninger, 1970; Mattson and Volpenhein, 1972). The rate of hydrolysis is depending on the structure of the ester, and may therefore be rapid or rather slow. Thus, due to hydrolysis, predictions on oral absorption based on the physico-chemical characteristics of the intact parent substance alone may no longer apply. Instead, the physico-chemical characteristics of the hydrolysis products (glycerol and 2-ethylhexanoic acid as well as the mono- and diesters) may become relevant. The molecular weight of propane-1,2,3-triyl 2-ethylhexanoate (470.7 g/mol) does favour absorption. In contrast, its low water solubility (< 0.05 mg/L, column elution method, EU A.6) and the high log Pow value (8.98, QSAR calculation with KOWWIN (v1.68)) indicate that the absorption may be limited by the inability to dissolve into GI fluids. However, micellar solubilisation by bile salts may enhance absorption, a mechanism which is especially of importance for highly lipophilic substances with log Pow > 4 and low water solubility (Aungst and Shen, 1986).
When considering the hydrolysis product glycerol, absorption is favoured based on passive and active absorption of glycerol (Lin, 1977; Yuasa, 2003). The other hydrolysis product 2-ethylhexanoic acid (molecular weight 144.21 g/mol; water solubility approx. 2 g/L; log Pow approx. 2.7; Danish (Q)SAR Database, 2019) is well absorbed via the GI tract. Peak plasma concentrations of 85.1 µg 2-ethylhexanoic acid equivalents per g blood were reached after 18.8 minutes following oral administration of 100 mg/kg bw of 2-ethylhexanoic acid (EPA, 1986). Mono- and diester could also be absorbed after micellar solubilisation by bile salts, similar to mono- and diester of fatty acids with glycerol.
In summary, while absorption of the parent compound propane-1,2,3-triyl 2-ethylhexanoate is considered to be limited after oral application, its hydrolysis products glycerol and 2-ethylhexanoic acid are anticipated to be absorbed to a high degree.
Dermal
There are no data available on dermal absorption or on acute dermal toxicity of propane-1,2,3-triyl 2-ethylhexanoate. On the basis of the following considerations, its dermal absorption is considered to be low. Regarding the molecular weight of 470.7 g/mol and an octanol/water partition coefficient of 8.98 in combination with the low water solubility, a low dermal absorption rate is anticipated. Log Pow values above 6, will decrease the rate of transfer between the stratum corneum and the epidermis and therefore absorption across the skin will be limited and uptake into the stratum corneum itself is slow (ECHA, 2017).
Inhalation
Propane-1,2,3-triyl 2-ethylhexanoate has a very low vapour pressure of < 0.0001 Pa at 20 °C (QSAR evaluation) thus being of low volatility. Therefore, under normal use and handling conditions, inhalation exposure and thus availability for respiratory absorption of the substance in the form of vapours, gases, or mists is not significant. However, the substance may be available for respiratory absorption in the lung after inhalation of aerosols, if the formulated substance is sprayed. In humans, particles with aerodynamic diameters below 100 μm have the potential to be inhaled. Particles with aerodynamic diameters below 50 μm may reach the thoracic region and those below 15 μm the alveolar region of the respiratory tract (ECHA, 2017).
As discussed above, absorption after oral administration of propane-1,2,3-triyl 2-ethylhexanoate may mainly be driven by enzymatic hydrolysis of the ester bonds to the respective hydrolysis products and subsequent absorption of the hydrolysis products. As the presence of esterases and lipases in the mucus lining fluid of the respiratory tract is expected to be lower in comparison to the GI tract, absorption of the hydrolysis products in the respiratory tract is considered to be less effective than in the GI tract. Nevertheless, absorption of the parent substance itself cannot be excluded if the propane-1,2,3-triyl 2-ethylhexanoate reaches the alveolar region. Therefore, inhalative absorption of propane-1,2,3-triyl 2-ethylhexanoate is considered to be not higher than through the intestinal epithelium, but still likely to occur.
Distribution and accumulation
Distribution of a compound within the body depends on the physico-chemical properties of the substance, especially the molecular weight, the lipophilic character and the water solubility. In general, the smaller the molecule, the wider is the distribution. If the molecule is lipophilic, it is likely to distribute into cells and the intracellular concentration may be higher than extracellular concentration particularly in fatty tissues (ECHA, 2017).
As the parent compound propane-1,2,3-triyl 2-ethylhexanoate may be hydrolysed before or after absorption as discussed above, the distribution of intact propane-1,2,3-triyl 2-ethylhexanoate as well as the distribution of the hydrolysis products needs to be considered. The absorbed hydrolysis products, glycerol and 2-ethylhexanoic acid, can both be distributed within the body. Data from studies in humans and animals indicate that glycerol is rapidly absorbed in the intestine and the stomach, distributed over the extracellular space (Lin 1977, Tourtelotte 1970) and excreted. The distribution of free 2-ethylhexanoic acid was monitored following intraperitoneal administration to male Balb/C mice and male Wistar rats. In the mouse most of the radioactivity was detected in the kidneys, the liver, and the GI tract 30 minutes after administration. At one hour small amounts were observed in the salivary gland, skin, and olfactory bulb. In the rat the highest levels were found in the blood, liver and kidneys. Small amounts were also observed in the brain (BG Chemie, 2000).
The parent compound propane-1,2,3-triyl 2-ethylhexanoate could be distributed into cells because of its lipophilic properties. An accumulation is, however, unlikely as enzymatic hydrolysis and further metabolism is anticipated.
Metabolism
Metabolism of propane-1,2,3-triyl 2-ethylhexanoate occurs initially via enzymatic hydrolysis resulting in glycerol, glycerol mono- or diester, and 2-ethylhexanoic acid. Glycerol is phosphorylated to alpha-glycerophosphate by glycerol kinase predominantly in the liver (80-90%) and kidneys (10-20%) and incorporated in the standard metabolic pathways to form glucose and glycogen (Lin 1977). Glycerol kinase is also found in intestinal mucosa, brown adipose tissue, lymphatic tissue, lung and pancreas. Glycerol may also be combined with free fatty acids in the liver to form triglycerides (lipogenesis) which are distributed to adipose tissues. The turnover rate is directly proportional to plasma glycerol levels (Bortz, 1972).
2-Ethylhexanoic acid metabolism was found to take place via conjugation with glucuronic acid as well as cytochrome P-450-dependent omega and omega-1 oxidation. The major urinary metabolites identified were the glucuronide of 2-ethylhexanoic acid as well as 2-ethyl-1,6-hexanedioic acid, 6-hydroxy-2-ethylhexanoic acid and their respective glucuronides. With increasing single dose, the fraction of glucuronidated 2-ethylhexanoic acid increased while the percentage of cytochrome P-450 dependent, more highly oxidised metabolites decreased (BG Chemie, 2000).
Excretion
Glycerol is fully metabolised and incorporated in standard metabolic pathways to form glucose and glycogen. Thus, low levels of glycerol may be excreted via urine whereas the rest is fully metabolised to CO2 via glycolysis and citric acid cycle.
In all available studies with 2-ethylhexanoic acid, irrespective of the route of administration employed, the radioactivity was predominantly excreted in the urine and faeces within 24 h, with half-lives of elimination ranging from 4.2 to 6.8 h.
References
Aungst B. and Shen D. D. (1986). Gastrointestinal absorption of toxic agents. In Rozman K. K. and Hanninen O. Gastrointestinal Toxicology. Elsevier, New York, US.
BG Chemie (2000) Toxicological evaluation No. 275, 2-Ethylhexanoic acid 06/00.
Bortz, W. (1972) Glycerol turnover and oxidation in man, The Journal of Clinical Investigation 51: 1537-1546 (34)
Danish (Q)SAR Database (2019). http://qsardb.food.dtu.dk/db/index.html; RN: 149-57-5; last accessed: 2019-04-01
ECHA (2017). Chapter R.7c: Endpoint specific guidance, ECHA-17-G-11-EN, version 3.0, June 2017, European Chemicals Agency
EPA (Environmental Protection Agency, 1986) 2-Ethyl hexanoic acid, final test rule, Federal Register, 51, 40318-40330.
Lehninger, A. L. (1970). Biochemistry. Worth Publishers, Inc.
Lin, E.C.C. (1977) Glycerol utilization and its regulation in mammals, Ann. Rev. Biochem. 46: 765-95 (52)
Long, C. L. et al. (1958). Studies on absorption and metabolism of propylene glycol distearate. Arch Biochem Biophys, 77(2):428-439.
Mattson F. H. and Volpenhein R. A. (1968). Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J Lip Res 9, 79-84.
Tourtellotte, M. D. et al. (1970) Cerebral dehydration action of glycerol, Clinical Pharmacology and Therapeutics 13(2): 159-171, (68)
Yuasa, H. (2003) Saturable absorption of glycerol in the rat intestine. Biological & Pharmaceutical Bulletin 26(11), 1633-6.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.